financetom
Business
financetom
/
Business
/
Boeing's Calhoun says its board is ready to make decisions for succession
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Boeing's Calhoun says its board is ready to make decisions for succession
Jun 4, 2024 5:29 AM

BERLIN, June 4 (Reuters) - Boeing's ( BA ) board is

prepared to make decisions as the planemaker's Chief Executive

David Calhoun is set to step down at the end of the year, he

told Reuters on Wednesday, adding that the decision on his

successor is up to the board.

"The board is prepared to make their decisions, they have

time to be able to make them," Calhoun said on the sidelines of

an aviation conference in Berlin, adding that he is committed to

getting the company through its recovery.

Calhoun is set to step down by year-end as part of a

broad management shakeup brought on by the planemaker's

sprawling safety crisis, exacerbated by a January mid-air panel

blowout on a new 737 MAX plane.

Speculation has grown over his successor. Calhoun

supports Stephanie Pope, the head of Boeing's ( BA ) commercial

division, while investors, analysts and others have called for a

new top executive with both CEO and engineering experience.

Calhoun has been a Boeing ( BA ) board member since 2009, and

was named CEO in 2020 to help turn the planemaker around

following two fatal crashes involving the MAX, its

strongest-selling jet.

However, the planemaker has lost market share to

competitor Airbus, with its stock losing nearly 32% of

its value this year as production of the MAX plummeted this

spring. Following the January 5 incident, which occurred on a

plane operated by Alaska Airlines, U.S. regulators have curbed

the company's production ceiling.

Boeing ( BA ) is also under renewed scrutiny from the U.S.

Justice Department, which is weighing whether to advance

criminal charges against the company for violating a

non-prosecution agreement stemming from the 2018 and 2019

crashes that killed nearly 350 people.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved